Jiangsu Nanfang Medical Co., Ltd. (SHA:603880)

Market Cap	1.87B +15.4%
Revenue (ttm)	594.86M +1.7%
Net Income	-202.28M
EPS	-0.70
Shares Out	289.04M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,460,706
Average Volume	7,987,818
Open	6.34
Previous Close	6.32
Day's Range	6.25 - 6.51
52-Week Range	4.60 - 7.75
Beta	0.25
RSI	43.47
Earnings Date	Apr 30, 2026

About Jiangsu Nanfang Medical

Jiangsu Nanfang Medical Co., Ltd. engages in the research and development, production, and sale of transdermal, medical proof fabrics, adhesive tapes and bandages, sports protection, first-aid kits, and care products in China and internationally. It offers medical wound dressings, capsicum plasters, physical therapy tapes, pain relief sleeves, rigid sports tapes, wound plaster dressings, medical eye pads, elastic stretch tapes, corn removal plasters, waterproof adhesive tapes, pain relief patches, kinesiology tapes, surgical tapes, zinc oxide a...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1990
• Employees: 850
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603880

Financial Performance

In 2024, Jiangsu Nanfang Medical's revenue was 602.62 million, an increase of 0.42% compared to the previous year's 600.10 million. Losses were -190.67 million, 29.3% more than in 2023.